第五章 中国与社会主义:结论
注1:Robert Weil, “On ‘Emancipating the Mind’,” Socialism and Democracy 15, no. 2(Fall 2001); Barbara Foley, “From Situational Dialectics to Pseudo-Dialectics: Mao, Jiang, and Capitalist Transition,” Cultural Logic, 2002, http://eserver.org/clog-ic/2002.
注2:Marx writing to the editorial board of Otecheshtvenniye Zapiski, November 1877, in Karl Marx and Frederick Engels, Selected Correspondence (Moscow: Progress Publishers, 1975), 294.
注3:David McNally, “Language, History, and Class Struggle,” Monthly Review 47, no. 3 (July/August 1995): 26-27.
注4:Ibid., 26.
注5:Clive Y. Thomas, Dependence and Transformation: The Economics of the Transition to Socialism (New York: Monthly Review Press, 1974).
注6:See, for example, Sergio Diaz-Briquets, The Health Revolution in Cuba (Austin: University of Texas Press, 1983):Julie Margot Feinsilver, Healing the Masses: Cuban Health Politics at Home and Abroad (Berkeley: University of California Press, 1993); Kamran Nayeri, “The Cuban Health Care System and Factors Currently Undermining It,” Journal of Community Health 20, no. 4 (August 1995); Amina Aitsiselme, “Despite U.S-Embargo, Cuban Biotech Booms,” NACLA Report on the Americas, 35, no.5 (March-April 2002); Mark Ingebretsen,” A Biotechnology Powerhouse Is Emerging Off Our Shores,” The Daily Scan (Wall Street Journal web-site), November 25, 2003; Ernesto Lopez Mola, Boris E. Acevedo, Ricardo Silva, Bianca Tormo, Ricardo Montero, and Luis Hen-era, “Development of Cuban Biotechnology,” Journal of Commercial Biotechnology’ 9, no. 2(January 2003); Reuters, “Cuban Vaccine to Help Poor Kids,” November 23, 2003.
注7:Paul Burkett and Martin Hart-Landsberg, Development, Crisis and Class Struggle: Learning from Japan and East Asia (New York: St.Martin Press, 2000), Chapters 11-12.